Fresenius SE Revenue 2016-2024 | FSNUY

Fresenius SE revenue for the twelve months ending September 30, 2024 was $23.561B, a 474.57% increase year-over-year.

  • Fresenius SE annual revenue for 2023 was $24.134B, a 0% decline from 2023.
  • Fresenius SE annual revenue for 2023 was $24.134B, a 43.91% decline from 2022.
  • Fresenius SE annual revenue for 2022 was $43.029B, a 0% decline from 2022.

Fresenius SE Revenue 2016-2024 | FSNUY

  • Fresenius SE annual revenue for 2023 was $24.134B, a 0% decline from 2023.
  • Fresenius SE annual revenue for 2023 was $24.134B, a 43.91% decline from 2022.
  • Fresenius SE annual revenue for 2022 was $43.029B, a 0% decline from 2022.
Related Stocks
Company NameMarket
Cap
Quest Diagnostics (DGX)$19.2B
DaVita (DVA)$12.4B
Encompass Health (EHC)$10.2B
Chemed (CHE)$8.4B
Elanco Animal Health (ELAN)$5.6B
Option Care Health (OPCH)$5.5B
RadNet (RDNT)$4.8B
LifeStance Health (LFST)$3.1B
Amedisys (AMED)$3B
Astrana Health (ASTH)$2.2B
Addus HomeCare (ADUS)$2.1B
U.S Physical Therapy (USPH)$1.3B
Aveanna Healthcare Holdings (AVAH)$968M
Pennant (PNTG)$927M
Atai Life Sciences (ATAI)$351M
Bioqual (BIOQ)$54M
Daxor (DXR)$35M
Ontrak (OTRK)$7M
MEDIROM Healthcare Technologies (MRM)$4M
IMAC Holdings (BACK)$1M
Psychemedics (PMD)$0M